Omar Pacha

Dermatology

1515 Holcombe Blvd
Houston, TX 77030

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors.

Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors.

Journal: Journal for immunotherapy of cancer

Published: July 16, 2025

A Dark Side of Calcium Channel Blockers: Increased Risk of Stasis Dermatitis.

A Dark Side of Calcium Channel Blockers: Increased Risk of Stasis Dermatitis.

Journal: International journal of dermatology

Published: January 14, 2025

Elevated risk of oral cancer in patients with lichen planus: a retrospective cohort study.

Elevated risk of oral cancer in patients with lichen planus: a retrospective cohort study.

Journal: Archives of dermatological research

Published: January 04, 2025

A retrospective case series of eight patients with epidermal growth factor receptor inhibitor-induced cutaneous toxicities managed with dupilumab.

A retrospective case series of eight patients with epidermal growth factor receptor inhibitor-induced cutaneous toxicities managed with dupilumab.

Journal: JAAD case reports

Published: November 25, 2024

Celiac disease associated with alopecia areata: A multicenter case-control study.

Celiac disease associated with alopecia areata: A multicenter case-control study.

Journal: Journal of the American Academy of Dermatology

Published: August 28, 2024

Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of TH 1 T-cells.

Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of TH 1 T-cells.

Journal: Journal of cutaneous pathology

Published: January 17, 2023

Erratum to "Periorbital edema associated with alpelisib" [Cancer Treatment and Research Communications 32 (2022) 100596].

Erratum to "Periorbital edema associated with alpelisib" [Cancer Treatment and Research Communications 32 (2022) 100596].

Journal: Cancer treatment and research communications

Published: December 03, 2022

Periorbital edema associated with alpelisib.

Periorbital edema associated with alpelisib.

Journal: Cancer treatment and research communications

Published: May 04, 2022

Skin Reactions to Immune Checkpoint Inhibitors.

Skin Reactions to Immune Checkpoint Inhibitors.

Journal: Advances in experimental medicine and biology

Published: January 01, 2022

A retrospective case series of 20 patients with immunotherapy-induced bullous pemphigoid with emphasis on management outcomes.

A retrospective case series of 20 patients with immunotherapy-induced bullous pemphigoid with emphasis on management outcomes.

Journal: Journal of the American Academy of Dermatology

Published: September 22, 2021

Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefit.

Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefit.

Journal: Cancer

Published: July 17, 2021

Surgical Intervention for Paronychia Induced by Targeted Anticancer Therapies.

Surgical Intervention for Paronychia Induced by Targeted Anticancer Therapies.

Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

Published: May 24, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026